Ford, Ian

Thyroid Function Within the Reference Range and the Risk of Stroke: An Individual Participant Data Analysis

Chaker, L., Baumgartner, C., den Elzen, W. P. J., Collet, T.-H., Ikram, M. A., Blum, M. R., Dehghan, A., Drechsler, C., Luben, R. N., Portegies, M. L. P., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism

Thyroid Disorders and TreatmentsAcute Ischemic Stroke Management

Cited by 92

Changes in the hippocampus and the cerebellum resulting from hypoxic insults: frequency and distribution

Ng, T., Graham, D. I., Adams, J. H., & Ford, I. (1989) · Acta Neuropathologica

Neurological Disease Mechanisms and TreatmentsCardiac Arrest and Resuscitation

Cited by 81

Efficacy and safety of ivabradine in patients with chronic systolic heart failure and diabetes: an analysis from the SHIFT trial

Komajda, M., Tavazzi, L., Francq, B. G., Böhm, M., Borer, J. S., Ford, I., & Swedberg, K. (2015) · European Journal of Heart Failure

Heart rate and cardiovascular healthHeart Failure Treatment and Management

Cited by 76

Annotation of loci from genome-wide association studies using tissue-specific quantitative interaction proteomics

The QT Interval International GWAS Consortium (QT-IGC), Lundby, A., Rossin, E. J., Steffensen, A. B., Acha, M. R., Newton-Cheh, C., Pfeufer, A., Lynch, S. N., Olesen, S.-P., Brunak, S., et al. (2014) · Nature Methods

Genetic Associations and EpidemiologyBioinformatics and Genomic Networks

Cited by 71

PCSK9 SNP rs11591147 is associated with low cholesterol levels but not with cognitive performance or noncardiovascular clinical events in an elderly population

Postmus, I., Trompet, S., de Craen, A. J. M., Buckley, B. M., Ford, I., Stott, D. J., Sattar, N., Slagboom, P. E., Westendorp, R. G. J., & Jukema, J. W. (2013) · Journal of Lipid Research

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 67

Specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchers

Cook, J. A., Hislop, J., Altman, D. G., Fayers, P., Briggs, A. H., Ramsay, C. R., Norrie, J. D., Harvey, I. M., Buckley, B., Fergusson, D., et al. (2015) · Trials

Statistical Methods in Clinical TrialsMeta-analysis and systematic reviews

Cited by 66

Does Low to Moderate Alcohol Intake Protect Against Cognitive Decline in Older People?

Stott, D. J., Falconer, A., Kerr, G. D., Murray, H. M., Trompet, S., Westendorp, R. G. J., Buckley, B., De Craen, A. J. M., Sattar, N., & Ford, I. (2008) · Journal of the American Geriatrics Society

Dementia and Cognitive Impairment ResearchAlcohol Consumption and Health Effects

Cited by 55

Clinical and metabolic features of the randomised controlled Diabetes Remission Clinical Trial (DiRECT) cohort

Taylor, R., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Sattar, N., Welsh, P., Peters, C., Zhyzhneuskaya, S., et al. (2018) · Diabetologia

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 55

Association between GDF-15 levels and changes in vascular and physical function in older patients with hypertension

Barma, M., Khan, F., Price, R. J. G., Donnan, P. T., Messow, C. M., Ford, I., McConnachie, A., Struthers, A. D., McMurdo, M. E. T., & Witham, M. D. (2017) · Aging Clinical and Experimental Research

GDF15 and Related BiomarkersFrailty in Older Adults

Cited by 47

Personality, Socio-Economic Status and Inflammation: Cross-Sectional, Population-Based Study

Millar, K., Lloyd, S. M., McLean, J. S., Batty, G. D., Burns, H., Cavanagh, J., Deans, K. A., Ford, I., McConnachie, A., McGinty, A., et al. (2013) · PLoS ONE

Health disparities and outcomesTryptophan and brain disorders

Cited by 47

Subclinical Thyroid Dysfunction and Functional Capacity Among Elderly

Virgini, V. S., Wijsman, L. W., Rodondi, N., Bauer, D. C., Kearney, P. M., Gussekloo, J., den Elzen, W. P. J., Jukema, J. W., Westendorp, R. G. J., Ford, I., et al. (2014) · Thyroid®

Thyroid Disorders and TreatmentsThyroid and Parathyroid Surgery

Cited by 44

Generalizability of the REDUCE-IT Trial in Patients With Stable Coronary Artery Disease

Picard, F., Bhatt, D. L., Ducrocq, G., Elbez, Y., Ferrari, R., Ford, I., Tardif, J.-C., Tendera, M., Fox, K. M., & Steg, P. G. (2019) · Journal of the American College of Cardiology

Fatty Acid Research and HealthLipoproteins and Cardiovascular Health

Cited by 39

Prevalence of diabetes and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicities

Mak, K.-H., Vidal-Petiot, E., Young, R., Sorbets, E., Greenlaw, N., Ford, I., Tendera, M., Ferrari, R., Tardif, J.-C., Udell, J. A., et al. (2022) · European Journal of Preventive Cardiology

Diabetes, Cardiovascular Risks, and LipoproteinsAcute Myocardial Infarction Research

Cited by 39

Psychological, social and biological determinants of ill health (pSoBid): Study Protocol of a population-based study

Velupillai, Y. N., Packard, C. J., Batty, G. D., Bezlyak, V., Burns, H., Cavanagh, J., Deans, K., Ford, I., McGinty, A., Millar, K., et al. (2008) · BMC Public Health

Health disparities and outcomesPublic Health and Social Inequalities

Cited by 36

A parallel group randomised open blinded evaluation of A cceptance and Commitment Therapy for d epression a fter p sychosis: Pilot t rial outcomes (ADAPT)

Gumley, A., White, R., Briggs, A., Ford, I., Barry, S., Stewart, C., Beedie, S., McTaggart, J., Clarke, C., MacLeod, R., et al. (2017) · Schizophrenia Research

Mindfulness and Compassion InterventionsSchizophrenia research and treatment

Cited by 34

Beneficial Effects of Ivabradine in Patients with Heart Failure, Low Ejection Fraction, and Heart Rate Above 77 b.p.m

Bouabdallaoui, N., O'Meara, E., Bernier, V., Komajda, M., Swedberg, K., Tavazzi, L., Borer, J. S., Bohm, M., Ford, I., & Tardif, J.-C. (2019) · ESC Heart Failure

Heart rate and cardiovascular healthHeart Failure Treatment and Management

Cited by 21

Are elevated circulating intercellular adhesion molecule 1 levels more strongly predictive of diabetes than vascular risk? Outcome of a prospective study in the elderly

for the Prospective Study of Pravastatin in the Elderly at Risk Trial Study Group, Sattar, N., Murray, H. M., Welsh, P., Blauw, G. J., Buckley, B. M., de Craen, A. J., Ford, I., Forouhi, N. G., Freeman, D. J., et al. (2009) · Diabetologia

Diabetes, Cardiovascular Risks, and LipoproteinsAdipokines, Inflammation, and Metabolic Diseases

Cited by 19

A parallel group randomised open blinded evaluation of Acceptance and Commitment Therapy for Depression After Psychosis: A Pilot Trial Protocol (ADAPT)

Gumley, A., White, R., Briggs, A., Ford, I., Barry, S., Stewart, C., Beedie, S., Clarke, C., MacLeod, R., Lidstone, E., et al. (2016) · Psychosis

Mindfulness and Compassion InterventionsSchizophrenia research and treatment

Cited by 2